$417 Million is the total value of Saltoro Capital, LP's 46 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GREEN PLAINS INCnote 4.125% 9/0 | $4,812,000 | -12.8% | 4,500,000 | 0.0% | 1.15% | -10.7% | ||
| TRAVERE THERAPEUTICS INCnote 2.500% 9/1 | $3,429,000 | -5.2% | 3,460,000 | 0.0% | 0.82% | -3.0% | ||
| INSMED INCnote 0.750% 6/0 | $2,511,000 | -13.6% | 3,000,000 | 0.0% | 0.60% | -11.5% | ||
| NABORS INDS INCnote 0.750% 1/1 | $1,840,000 | -3.2% | 2,000,000 | 0.0% | 0.44% | -0.9% | ||
| ACCELERATE DIAGNOSTICS INCnote 2.500% 3/1 | $1,360,000 | +2.2% | 2,000,000 | 0.0% | 0.33% | +4.8% | ||
| OMEROS CORPnote 6.250%11/1 | $1,116,000 | -4.0% | 1,250,000 | 0.0% | 0.27% | -1.8% | ||
| ACORDA THERAPEUTICS INCnote 6.000%12/0 | $1,110,000 | -2.4% | 1,500,000 | 0.0% | 0.27% | 0.0% | ||
| TILRAY BRANDS INCnote 5.000%10/0 | $920,000 | -4.2% | 1,000,000 | 0.0% | 0.22% | -2.2% | ||
| TEAM INCnote 5.000% 8/0 | $668,000 | +1.2% | 750,000 | 0.0% | 0.16% | +3.9% | ||
| CHKEL | CHESAPEAKE ENERGY CORP*w exp 02/09/202 | $383,000 | -5.7% | 7,302 | 0.0% | 0.09% | -3.2% | |
| XERIS BIOPHARMA HOLDINGS INCnote 5.000% 7/1 | $227,000 | -21.5% | 250,000 | 0.0% | 0.05% | -20.6% | ||
| CHK | CHESAPEAKE ENERGY CORP | $68,000 | -6.8% | 843 | 0.0% | 0.02% | -5.9% | |
| ALGOMA STL GROUP INC*w exp 10/19/202 | $41,000 | -37.9% | 20,000 | 0.0% | 0.01% | -33.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2022-08-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GREEN PLAINS INC | 12 | Q3 2023 | 6.5% |
| XERIS PHARMACEUTICALS INC | 12 | Q3 2023 | 0.3% |
| ACORDA THERAPEUTICS INC | 11 | Q3 2023 | 1.0% |
| TEAM INC | 11 | Q2 2023 | 0.9% |
| CHESAPEAKE ENERGY CORP | 11 | Q3 2023 | 0.5% |
| ISHARES TR | 10 | Q3 2023 | 49.6% |
| GREEN PLAINS INC | 10 | Q3 2023 | 8.8% |
| GREEN PLAINS INC | 9 | Q3 2023 | 6.2% |
| NABORS INDS INC NEW | 9 | Q2 2023 | 2.0% |
| TRAVERE THERAPEUTICS INC | 8 | Q3 2022 | 1.4% |
View Saltoro Capital, LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-10 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR/A | 2022-08-17 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-12 |
| 13F-HR/A | 2022-02-09 |
View Saltoro Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.